Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 004310317 approvals47 trials

HYUNDAI PHARMACEUTICAL CO., LTD

Official website

KOSPI-listed pharma, food, and cosmetics company behind Diemduo dementia treatment and Miero Fiber drink (2.1bn+ bottles sold).

As of 2026-10-10, HYUNDAI PHARMACEUTICAL CO., LTD has 35 Korean MFDS device approvals, 282 Korean MFDS drug approvals, 8 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1965 and listed on the KOSPI in 1978, Hyundai Pharmaceutical is a comprehensive pharmaceutical, food, and cosmetics company. It sells the dementia treatments Diemduo Tab. and Tamillin Tab. and the dyslipidemia treatment Ezepheno Tab. as prescription drugs, along with the OTC brands Minoxil, Bemuly (insect-bite treatment), and Rooping (artificial tears), while operating the dietary fiber drink Miero Fiber and the cosmetics brands LABCLE (skincare) and MINOXELL (scalp/hair-loss care). Launched in 1989, Miero Fiber has sold over 2.1 billion bottles cumulatively; the company released Miero Fiber Sparkling Zero in 2024 and Miero Fiber Salt Lemon and Kids in 2025, and after entering the cosmetics business in March 2021 is expanding into Olive Young (from January 2026) and other online/offline channels.

Products & technology

  • Diemduo Tab.Dementia treatment
  • Tamillin Tab.Dementia treatment
  • Ezepheno Tab.Dyslipidemia treatment
  • MinoxilFlagship OTC brand
  • BemulyInsect-bite treatment
  • RoopingArtificial tears
  • Miero FiberDietary fiber drink
  • LABCLESkincare cosmetics
  • MINOXELLScalp and hair-loss care cosmetics

Regulatory approvals

data.go.kr

282 Korean MFDS drug approvals · 1976–2026 / 35 Korean MFDS device approvals · 1999–2017

  • MFDS drugDermatoning cream2026-09-30
    Drug · OTC · Notification202602926
  • MFDS drugHyundai Minoxidil Tab. 2.5mg2025-11-11
    Drug · Prescription · Approval202502909
  • MFDS drugBrilact Tab. 10mg2025-10-24
    Drug · Prescription · Approval202502740
  • MFDS drugBrilact Tab. 50mg2025-10-24
    Drug · Prescription · Approval202502741
  • MFDS drugBrilact Tab. 25mg2025-10-24
    Drug · Prescription · Approval202502746
  • MFDS drugBrilact Tab. 100mg2025-10-24
    Drug · Prescription · Approval202502747
  • MFDS drugWinlevi Cream2025-09-29
    Drug · Prescription · Approval202502573
  • MFDS drugCandevaro Tab. 8/2.5mg2025-07-24
    Drug · Prescription · Approval202501883
  • MFDS drugCandevaro Tab. 16/5mg2025-07-24
    Drug · Prescription · Approval202501884
  • MFDS drugCandevaro Tab. 16/2.5mg2025-07-24
    Drug · Prescription · Approval202501885
  • MFDS drugDespri ER tab. 100mg2025-01-10
    Drug · Prescription · Approval202500083
  • MFDS drugDespri ER Tab. 50mg2025-01-09
    Drug · Prescription · Approval202500081
Show 68 more
  • MFDS drugDoongeun Muri Bumooly S Gel2024-11-22
    Drug · OTC · Notification202402764
  • MFDS drugBody drant Sol.2024-10-22
    Drug · OTC · Notification202402493
  • MFDS drugDMduo tablet 10/20mg2024-10-18
    Drug · Prescription · Approval202402462
  • MFDS drugEXPRAM Tablet(Escitalopram oxalate)2024-09-23
    Drug · Prescription · Approval202402283
  • MFDS drugSlinda 4mg tablet(Drospirenone)2024-08-13
    Drug · Prescription · Approval202401957
  • MFDS drugMINOXYL Foam Aerosol 5%2024-08-02
    Drug · OTC · Notification202401876
  • MFDS drugSinocaN Plus Soft Cap.2024-06-28
    Drug · OTC · Notification202401591
  • MFDS drugNiserin Tab. 10mg2024-06-24
    Drug · Prescription · Approval202401519
  • MFDS drugLeaflin Tab. 240mg2024-06-20
    Drug · OTC · Notification202401490
  • MFDS drugSinoflu Cold Cap.2024-06-10
    Drug · OTC · Notification202401420
  • MFDS drugHyundaiarami Tab.2024-03-04
    Drug · OTC · Notification202400445
  • MFDS drugHyundaiarabi Tab.2024-03-04
    Drug · OTC · Notification202400455
  • MFDS drugMetarosine Ointment (Mupirocin)2024-02-29
    Drug · OTC · Notification202400424
  • MFDS drugNiserin Tab. 30mg2024-01-08
    Drug · Prescription · Approval202400054
  • MFDS drugAbilapin tablet 1mg(Aripiprazole)2024-01-05
    Drug · Prescription · Approval202400040
  • MFDS drugAbilapin tablet 2mg(Aripiprazole)2024-01-05
    Drug · Prescription · Approval202400041
  • MFDS drugSertarin Tab. 100mg2023-12-29
    Drug · Prescription · Approval202303462
  • MFDS drugSertarin Tab. 50mg2023-12-29
    Drug · Prescription · Approval202303463
  • MFDS drugMonkarizine Tab.2023-10-30
    Drug · Prescription · Approval202303017
  • MFDS drugSertarin Tab. 25mg2023-10-25
    Drug · Prescription · Approval202302988
  • MFDS drugSitapio 100mg/30mg Tab.2023-07-31
    Drug · Prescription · Approval202302297
  • MFDS drugSitapio 100mg /15mg Tab.2023-07-31
    Drug · Prescription · Approval202302298
  • MFDS drugHipezil Tab. 3mg2023-06-28
    Drug · Prescription · Approval202301978
  • MFDS drugsitadual 50/850 tab.2023-03-13
    Drug · Prescription · Approval202300860
  • MFDS drugsitadual 50/500 tab.2023-03-13
    Drug · Prescription · Approval202300861
  • MFDS drugsitadual 50/1000 tab.2023-03-13
    Drug · Prescription · Approval202300862
  • MFDS drugsitadual XR 50/500 tab.2023-02-17
    Drug · Prescription · Approval202300584
  • MFDS drugsitadual XR 50/1000 tab.2023-02-17
    Drug · Prescription · Approval202300585
  • MFDS drugsitadual XR 100/1000 tab.2023-02-17
    Drug · Prescription · Approval202300586
  • MFDS drugDimantin Tab. 20mg2022-10-28
    Drug · Prescription · Approval202203939
  • MFDS drugDinafen Cataplasma(Diclofenac Sodium)2022-05-26
    Drug · OTC · Notification202202254
  • MFDS drugHipezil powder 5mg, Hipezil powder 10mg2022-04-11
    Drug · Prescription · Approval202201524
  • MFDS drugSugadion prefilled Inj.(Sugammadex sodium)2022-02-14
    Drug · Prescription · Approval202200703
  • MFDS drugToparin Tab.25mg(topiramate)2022-01-11
    Drug · Prescription · Approval202200266
  • MFDS drugMetaji cream2021-12-15
    Drug · OTC · Notification202107980
  • MFDS drugEzefeno Tab.2021-10-14
    Drug · Prescription · Approval202106924
  • MFDS drugLEVOTUSS CR Tab. 90mg(Levodropropizine)2021-06-30
    Drug · Prescription · Approval202104979
  • MFDS drugIVAPTEN SOLUTION(benzydamine hydrochloride)2021-06-29
    Drug · OTC · Notification202104954
  • MFDS drugSitadaun Tab. 50mg (Sitagliptin Hydrochloride Hydrate)2021-03-19
    Drug · Prescription · Approval202102463
  • MFDS drugSitadaun Tab. 25mg (Sitagliptin Hydrochloride Hydrate)2021-03-19
    Drug · Prescription · Approval202102464
  • MFDS drugSitadaun Tab. 100mg (Sitagliptin Hydrochloride Hydrate)2021-03-19
    Drug · Prescription · Approval202102465
  • MFDS drugYaroz tab.2021-02-16
    Drug · Prescription · Approval202101322
  • MFDS drugLuthiforce Inj. 600mg2020-12-10
    Drug · Prescription · Notification202008677
  • MFDS drugVitafolio inj.2020-11-26
    Drug · Prescription · Notification202008261
  • MFDS drugUrintamin Cap.2020-11-18
    Drug · OTC · Notification202007980
  • MFDS drugBENFOACTIVE PREMIUM Tab.2020-11-16
    Drug · OTC · Notification202007893
  • MFDS drugCholecalD Inj. (Cholecalciferol)2020-11-06
    Drug · Prescription · Notification202007637
  • MFDS drugHyundai Bromelain Enteric Coated Tablet 45mgRevoked2020-10-29
    Drug · OTC · Notification202007414
  • MFDS drugSENSELAC-U soft Cap.2020-10-19
    Drug · OTC · Notification202007142
  • MFDS drugNeurobera Inj.2020-10-14
    Drug · Prescription · Notification202007031
  • MFDS drugBENFOACTIVE Soft Cap.2020-10-13
    Drug · OTC · Notification202006967
  • MFDS drugHyalping eye drop(Sodium Hyaluronate)2020-07-21
    Drug · OTC · Notification202005203
  • MFDS drugKeprotec Cataplasma(Ketoprofen)2020-07-09
    Drug · OTC · Notification202004950
  • MFDS drugDexnoxyl Tab. (Dexpanthenol)2020-06-15
    Drug · OTC · Notification202004385
  • MFDS drugAminofos Inj.2020-06-09
    Drug · Prescription · Notification202004300
  • MFDS drugRibonuen Inj. (Polydeoxyribonucleotide Sodium)2020-06-02
    Drug · Prescription · Notification202004186
  • MFDS drugHyundai Solifenacin Succinate Tab. 10mgRevoked2020-04-09
    Drug · Prescription · Approval202002516
  • MFDS drugHyundai Solifenacin Succinate Tab. 5mgRevoked2020-04-09
    Drug · Prescription · Approval202002517
  • MFDS drugAtoromin Tab. 20mg (Atorvastatin calcium trihydrate)2020-03-31
    Drug · Prescription · Approval202002211
  • MFDS drugAtoromin Tab. 10mg (Atorvastatin calcium trihydrate)2020-03-31
    Drug · Prescription · Approval202002212
  • MFDS drugSoxital Tab.2020-03-19
    Drug · OTC · Notification202001961
  • MFDS drugLacopat Syrup (Lacosamide)2020-01-22
    Drug · Prescription · Approval202000376
  • MFDS drugCirozeno Cap. (Cetirizine Dihydrochloride)2020-01-06
    Drug · OTC · Notification202000062
  • MFDS drugBumooly alpha Sol.2019-12-23
    Drug · OTC · Notification201908589
  • MFDS drugCinotadine soft Cap. (Loratadine)2019-12-20
    Drug · OTC · Notification201908562
  • MFDS drugHyundai Fluoxetine Cap. 20mg2019-11-05
    Drug · Prescription · Approval201907731
  • MFDS drugHyundai Fluoxetine Cap. 10mg2019-11-05
    Drug · Prescription · Approval201907732
  • MFDS drugRasazilt Tab. 1 mg (Rasagiline Mesylate)2019-10-30
    Drug · Prescription · Approval201907566

Showing the 80 most recent of 317 records.

Clinical trials

data.go.kr

47 MFDS clinical trial authorisations · 2012–2026 (Phase 1 25 · Bioequivalence 13 · Phase 3 6 · Phase 2 2 · Phase 1/2 1)

  • Phase 3HODO-25222026-07-15

    1 trial site

  • Phase 1HDNO-16052026-04-28

    1 trial site

  • Phase 1BSDO-23012026-04-08

    2 trial sites

  • Phase 3BSDO-23012025-07-30

    34 trial sites

  • BioequivalenceHOGO-24072025-03-06

    2 trial sites

  • Phase 1HODO-22252025-02-20

    2 trial sites

  • Phase 3HODO-22242025-02-11

    1 trial site

  • Phase 1HODO-22242024-10-24

    2 trial sites

  • Phase 1HODO-23122024-09-30

    2 trial sites

  • Phase 1BSDO-23012024-08-19

    2 trial sites

  • Phase 1HODO-22252024-05-14

    2 trial sites

  • Phase 2HDNO-16052024-04-08

    2 trial sites

Show 35 more
  • Phase 1HDNO-16052024-03-20

    1 trial site

  • Phase 1HODO-23052024-03-14

    1 trial site

  • Phase 1HODO-22242023-11-20

    2 trial sites

  • BioequivalenceHOGO-22112023-06-16

    2 trial sites

  • Phase 1HODO-22062023-04-24

    1 trial site

  • BioequivalenceHOGO-23062023-04-17

    1 trial site

  • BioequivalenceHOGO-20742022-10-21

    1 trial site

  • BioequivalenceHOGO-21292022-08-09

    1 trial site

  • BioequivalenceBSDO-19062022-07-27

    2 trial sites

  • Phase 1BPDO-16032022-06-24

    1 trial site

  • Phase 2HDNO-16052022-03-18

    11 trial sites

  • Phase 1LINO-17132021-07-13

    1 trial site

  • Phase 1HDDO-17562020-04-13

    1 trial site

  • Phase 1HDDO-18012019-10-11

    2 trial sites

  • BioequivalenceHDDO-17282019-07-31

    2 trial sites

  • Phase 3BPDO-16032019-07-16

    52 trial sites

  • Phase 1HDDO-16092018-12-21

    1 trial site

  • BioequivalenceHDGO-1701(라사길린메실산염)2018-06-18

    2 trial sites

  • Phase 1BPDO-16032018-03-23

    1 trial site

  • Phase 1HDDO-16142017-09-14

    1 trial site

  • Phase 1BPDO-16032017-09-08

    1 trial site

  • Phase 1HDDO-16142017-03-13

    1 trial site

  • Phase 1/2더마화이트크림(HTB-003)2017-01-18

    1 trial site

  • Phase 3HOB-0482017-01-04

    10 trial sites

  • Bioequivalence디고틴정25mg(아고멜라틴)2016-12-12

    2 trial sites

  • Bioequivalence라코사미드정100mg(가칭)2016-04-08

    2 trial sites

  • Bioequivalence현대야로즈정(가칭)2015-11-16

    2 trial sites

  • Phase 1라코사마이드CR정2015-03-03

    1 trial site

  • Phase 3설포라제 서방정2015-01-08

    6 trial sites

  • Bioequivalence하이페질정23밀리그램(도네페질염산염)2014-08-26

    2 trial sites

  • Bioequivalence타미린서방정8밀리그램(갈란타민브롬화수소산염)2014-06-30

    2 trial sites

  • Phase 1설포라제 서방정2014-03-10

    1 trial site

  • Phase 1설포라제 서방정2013-09-26

    1 trial site

  • Phase 1콜린알포세레이트CR정2013-01-17

    1 trial site

  • Phase 1설포라제 서방정2012-05-11

    1 trial site

Global clinical trials

ClinicalTrials.gov · sponsor-matched
Show 1 more trials

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 88 more patents

AI reads

MAA server logs · IP-verified
91
Times AI engines pulled HYUNDAI PHARMACEUTICAL CO., LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

2
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

89
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

12
live 0
Last 7 days
67
live 2
Last 30 days
91
live 2
All time
  • OpenAIChatGPT-Userlive2
  • OpenAIOAI-SearchBot79
  • GoogleGoogleOther5
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for HYUNDAI PHARMACEUTICAL CO., LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

DONG-A ST CO.,LTD6 shared

Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.

SEJONG MEDICAL Co.Ltd.,2 shared

Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.

JMT CO.,Ltd.2 shared

Provides EMS and SMT manufacturing services for TFT-LCD and OLED panel driver PBAs.

DongKook Life Science Co., Ltd.2 shared

Founded in 2017 and KOSDAQ-listed in 2025, DongKook Life Science makes contrast agent products and distributes medical devices.

Alpha AI Co.,Ltd.2 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

MITECH CO.,LTD.2 shared

MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.

CUREXO, INC.1 shared

Develops and sells surgical robots Cuvis-joint/Cuvis-spine and the rehabilitation robot Morning Walk.

DongBang Medical Co., Ltd.1 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

Boryung Corporation1 shared

Founded in 1963 and listed in 1988, Boryung is a pharmaceutical and CDMO firm built around its antihypertensive drug Kanarb.

ChoA Pharmaceutical Co., LTD.1 shared

Founded in 1996 and listed on KOSDAQ in 1999, ChoA Pharmaceutical is an OTC-focused drugmaker exporting to 23 countries worldwide.

CLASSYS Inc.1 shared

CLASSYS Inc., established in 2015 and listed on KOSDAQ, makes aesthetic medical devices using HIFU, MRF, MNRF, and laser technologies.

SAMSUNG PHARMACEUTICAL.CO.,Ltd.1 shared

Samsung Pharmaceutical (est. 1929, KOSPI 1975) is a Gemvax & Kael affiliate selling Kasmyungsu and developing GV1001 biotech pipelines.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition